Vascular inflammation during human rickettsioses: An essential host response and a potential target for supplemental therapy

Keyphrases

• Vascular Inflammation 100%
• Endothelial Cells 100%
• Rickettsioses 100%
• Rickettsia 100%
• Host Response 100%
• Supplemental Therapy 100%
• Rickettsial 66%
• Apoptosis 33%
• Nuclear factor-κB 33%
• Host Cell 33%
• Intracellular Pathogen 33%
• Virulence 33%
• Innate Immune Response 33%
• Immunoreactive Cells 33%
• Epidemic Typhus 33%
• Signaling Interactions 33%
• Host Defense 33%
• Pathologic 33%
• Vascular Endothelium 33%
• Mitogen-activated Protein Kinase 33%
• Host Inflammation 33%
• Rickettsial Infection 33%
• Organ-specific 33%
• Spotted Fever Group Rickettsiae 33%
• Cell Survival 33%
• Rickettsia Conorii 33%
• Blood Vessels 33%
• In Vivo Model 33%
• Vascular Bed 33%
• Proteobacteria 33%
• Rickettsia Rickettsii 33%
• Obligate Intracellular 33%
• In Vitro Infection 33%
• Humankind 33%
• Cell Signaling 33%
• Existing Knowledge 33%
• 20th Century 33%
• Small-sized 33%
• Induced Oxidative Stress 33%
• Emerging Pathogen 33%
• Endothelial-like Cells 33%
• Apoptotic Cell Death 33%
• Arthropod-borne 33%
• Human Umbilical Vein Endothelial Cells (HUVECs) 33%
• P38 MAP Kinase 33%
• Mechanism of Death 33%
• Anti-inflammatory Strategies 33%
• Review Feature 33%
• Medium Size 33%
• Endothelial Heterogeneity 33%
• Vascular Graft Infection 33%

Medicine and Dentistry

• Infection 100%
• Immune Response 100%
• Endothelial Cell 100%
• Vasculitis 100%
• Rickettsia 100%
• Programmed Cell Death 66%
• In Vitro 33%
• Oxidative Stress 33%
• Host Cell 33%
• Sequela 33%
• Cell Line 33%
• Host Resistance 33%
• Innate Immunity 33%
• Pathogen 33%
• Immunoglobulin Enhancer Binding Protein 33%
• Vascular Endothelium 33%
• Infancy 33%
• Rickettsiosis 33%
• Signal Transduction 33%
• Epidemic Typhus 33%
• Immunocompetent Cell 33%
• Cell Survival 33%
• Spotted Fever 33%
• Mitogen Activated Protein Kinase P38 33%
• Rickettsia rickettsii 33%
• Proteobacteria 33%
• Anti-Inflammatory Drug 33%
• Vascular Bundle 33%
• Human Umbilical Vein Endothelial Cell 33%
• Emerging Pathogen 33%